"ARP III Consultation Draft of ARP III Recommendations", 17 Feb 2020

This document is a consultation draft of sections of a forthcoming report by the UN High Commissioner for Human Rights to the UN Human Rights Council in which the High Commissioner will set out recommended action to improve accountability and access to remedy for victims of business-related human rights abuse through non-State-based grievance mechanisms...

This consultation draft has been compiled as part of the Accountability and Remedy Project of the Office of the United Nations High Commissioner for Human Rights (OHCHR), pursuant to the request of the Human Rights Council in its resolution 38/13.  In that resolution, the Human Rights Council welcomed OHCHR’s prior work on improving accountability and access to remedy for victims of business-related human rights abuse, and requested OHCHR to continue its work in this area, specifically: 

"to identify and analyse challenges, opportunities, best practices and lessons learned with regard to non-State-based grievance mechanisms that are relevant to the respect by business enterprises for human rights, . . . and to submit a report thereon to the Human Rights Council for consideration at its forty-fourth session.”...

Following the approach used in previous phases of the Project, the High Commissioner’s report will include an annex containing a set of recommended “policy objectives” for States and non-State actors, supported by a series of “elements” intended to demonstrate ways that different actors (both State and non-State) can work towards meeting those objectives... 

The purpose of this consultation draft is to elicit feedback from all relevant stakeholders on the following questions:

(a)    Do you agree with the policy objectives and elements appearing in Annex I? If not, please explain why and provide suggestions as to how they should be set out?

(b)   Are there any further suggestions for elements of good practice related to the issues covered in Annex I?

 [All feedback should be sent to business-access2remedy[at]ohchr.org by 1 April 2020.]